Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2007
12/18/2007CA2305446C Phosphonium salt composition
12/18/2007CA2209001C Hydrophobic taxane derivatives
12/13/2007WO2007141877A1 Process for production of aminated phosphoric acid ester compound, flame-retardant resin, and flame-retardant resin composition
12/13/2007WO2007140717A1 C2-symmetrical ruthenocene diphosphine ligands only with surface chirality and their manufacture.
12/13/2007WO2007140662A1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof
12/13/2007WO2007109881A8 Biomarkers useful for diagnosing prostate cancer, and methods thereof
12/13/2007WO2007084211A3 Use of gpr54 ligands for treatment of reproductive disorders, proliferative disorders, and for contraception
12/13/2007WO2007082206A3 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
12/13/2007WO2007079272A3 Diaryl alkylphosphonates and methods for preparing same
12/13/2007WO2007044796A3 Pyridazinone compounds as calcilytics
12/13/2007WO2007022243A3 Bidentate catalyst for olefin polymerization, methods of forming such and products therefrom
12/13/2007US20070287869 Ionic Liquids Having Uronium Or Thiouronium Cations
12/13/2007US20070287858 Methods for synthesizing phosphonic compounds and compounds thereof
12/13/2007US20070287847 Ligand Synthesis
12/12/2007EP1864991A1 Organic ligands for semiconductor nanocrystals
12/12/2007EP1864990A1 Preparation of secondary phosphines
12/12/2007EP1864989A1 Method for producing l-2-amino-4-(hydroxymethylphosphinyl)- butanoic acid
12/12/2007EP1863824A2 Control of n-(phosphonomethyl) iminodiacetic acid conversion in manufacture of glyphosate
12/12/2007EP1863747A1 Hydroformylation process with improved iso-selectivity
12/12/2007EP1863572A2 New class of t cells activators and use thereof
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007CN101087800A Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
12/12/2007CN101085786A Method for preparing adefovir monoesters and method of detecting content of the same
12/12/2007CN101085785A Purine compounds for curing hepatitis B, preparation method and use thereof, and composition containing the compounds
12/12/2007CN101085784A Heating hydrolysis production method for glyphosate acid
12/12/2007CN101085783A Method for hydrolyzing glyphosate acid
12/12/2007CN101085782A Rare earth phosphor-containing organic complex and its preparation method and use
12/12/2007CN101085743A Fluorine-containing alkoxy combretastatin derivative, preparation method and use thereof
12/12/2007CN100354284C Preparation of triazoline artificial semi-antigen, antigen and antibody
12/12/2007CN100354260C Phthalamide derivative, agricultural or horticultural insecticide, and method of use thereof
12/12/2007CN100354256C Preparation of iminodiacetic acid compounds from monoethanolamine substrates
12/11/2007US7307166 8-Substituted purines; ring-cleaved aldose (guanosine 2',3' dialcohol); inflammatory diseases and bacterial infections; modifying hematopoiesis in animals with damage caused by irradiation, chemotherapy, poisoning; improve host leukocyte-mediated defenses against infection.
12/11/2007US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide
12/11/2007US7307065 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents
12/11/2007US7307037 Metallic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors
12/11/2007CA2442288C A novel catalytic formulation and its preparation
12/11/2007CA2224426C Cis-9,10-octadecenoamidase
12/06/2007WO2007139729A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase
12/06/2007WO2007139176A1 Phosphine transition metal complex, method for producing the same and antitumor agent
12/06/2007WO2007137410A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/06/2007WO2007137319A2 Preparation of secondary phosphines
12/06/2007WO2007104679B1 Polymerisation of ethylene and alpha-olefins with phosphino-iminophenol complexes
12/06/2007WO2007062168A3 Methods and compositions for the treatment of gastrointestinal disorders
12/06/2007WO2007013097A8 Improved process for the preparation of ibandronate sodium
12/06/2007US20070282130 Method for Hydroformylating Olefins in the Presence of Organophosphoric Compounds
12/06/2007US20070282120 Sphingomyelin, Intermediates Thereof and Methods For Preparation Of Same
12/06/2007US20070281910 Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereof
12/06/2007US20070281909 Creatine phosphate prodrugs, compositions and uses thereof
12/06/2007US20070281308 Chemically modified oligonucleotide primers for nucleic acid amplification
12/06/2007CA2835964A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/06/2007CA2653926A1 Methods and reagents for detecting bioactive lipids
12/06/2007CA2652869A1 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase
12/06/2007CA2651724A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/05/2007EP1862444A2 Ether compounds, compositions, and uses thereof
12/05/2007EP1861356A1 Imines as ion channel modulators
12/05/2007EP1861200A2 Unsymmetrically substituted phospholane catalysts
12/05/2007EP1263752B1 Lpa receptor agonists and antagonists and methods of use
12/05/2007EP1240213B1 Method of polymerization
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007CN101084289A Light emitting complex salts
12/05/2007CN101084231A Phosphoindoles as HIV inhibitors
12/05/2007CN101084191A Process for making substituted piperidines
12/05/2007CN101081854A C15phosphonate ester compound, preparation method application thereof
12/05/2007CN100352824C Method of making phosphorochloridites and method for producing N,N-dialkyl group diaryl azyl phosphinic acid ester
12/05/2007CN100352823C Preparation method of adenine derivative
12/05/2007CN100352822C Derivatives of thiophosphamide insecticide
12/04/2007US7304163 Benzotriazole-1-yl-N-oxy phosphonium coupling agent
12/04/2007US7304093 Ketone compounds and compositions for cholesterol management and related uses
12/04/2007US7304046 Phosphoramide compounds
12/04/2007US7303760 Method for treating multi-drug resistant tumors
12/04/2007US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
12/04/2007CA2418125C Beta-lactams useful in the preparation of substituted isoserine esters
12/04/2007CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof
11/2007
11/29/2007WO2007136650A2 Method and compositions for treating hematological malignancies
11/29/2007WO2007135179A1 Chiral ligands used in transition metal catalysts for asymmetric addition reactions especially hydrogenation
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007WO2007083243A3 An improved process for the preparation of risedronate sodium hemi-pentahydrate
11/29/2007WO2007078859A3 Tetraphosphorus ligands for catalytic hydroformylation and related reactions
11/29/2007WO2007045893A3 Beta adrenergic receptor pharmacophore
11/29/2007WO2002028345A3 Aldehyde-releasing compounds
11/29/2007US20070276153 Diastereoselective Method of Preparing Olefins by Means of the Horner-Wadsworth-Emmons Reaction Using a Particular Phosphonate Which Improves Diastereoselectivity at all Temperatures Including at Ambient Temperature
11/29/2007US20070275988 Transition state structure and inhibitors of thymidine phosphorylases
11/29/2007US20070275931 Bisphosphonate compounds and methods
11/29/2007US20070275090 Ionic Uv-A Sunscreens and Compositions Containing Them
11/29/2007CA2653150A1 Chiral ligands used in transition metal catalysts for asymmetric addition reactions especially hydrogenation
11/28/2007EP1859656A2 Organometallic complexes
11/28/2007EP1858912A2 Compounds for reducing aggregation of amyloid beta-peptide
11/28/2007EP1858889A1 Bicyclic nucleosides and nucleotides as therapeutic agents
11/28/2007EP1723157B1 Amorphous forms of risedronate monosodium
11/28/2007EP1697390B1 Method for producing organoacylphosphites
11/28/2007EP1685143B1 Method for the production of mono(fluoroalkyl)phosphoranes, bis(fluoroalkyl)phosphoranes, and the corresponding acids and phosphates
11/28/2007EP1232161B1 Mixed metal alkoxide complexes and polymerization catalysts made therefrom
11/28/2007CN100351298C Flame-retardant processed product
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351233C Fullerene derivative of E-isomer
11/27/2007US7301043 Platelet-Activating Factor Acetylhydrolase; for diagnosis of various conditions; eg 1-O-{(10-[4-(pyrene-1-yl)-butoxy]-decyl}-2-(6-(2,4-dinitrophenyl)-aminohexoyl)-rac-glycero-3-phosphocholine
11/27/2007US7301042 Reducing volatile organic compound emissions while making the sulfur vulcanized rubber
11/27/2007US7301040 Bidentate catalyst for olefin polymerization, methods of forming such and products therefrom
11/27/2007US7300904 Trimerization of ethylene with a catalyst system comprising a coordination catalyst of a chromium source complexed with a di(alkylsulfanylalkyl)amino or phosphino ligand, and an alumoxane; improved catalyst selectivity
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 554